排序方式:
1.Eltrombopag for chronic immune thrombocytopenia Reply
Cheng, G, Saleh, MN,
More...
Cheng, G, Saleh, MN, Marcher, C, Aivado, M, Brainsky, A, Bussel, JB
Less
LANCET[0140-6736],
Published 2011,
Volume 377,
Issue 9781,
Pages 1919-1920
收錄情况:
WOS
SCOPUS
WOS核心合集引用: 0
2023影響因子:
98.4
发表年影響因子:
38.278
2.Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study
Cheng, G, Saleh, MN,
More...
Cheng, G, Saleh, MN, Marcher, C, Vasey, S, Mayer, B, Aivado, M, Arning, M, Stone, NL, Bussel, JB
Less
LANCET[0140-6736],
Published 2011,
Volume 377,
Issue 9763,
Pages 393-402
收錄情况:
WOS
SCOPUS
WOS核心合集引用: 414
2023影響因子:
98.4
发表年影響因子:
38.278
3.Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial
Bussel, JB, Provan,
More...
Bussel, JB, Provan, D, Shamsi, T, Cheng, G, Psaila, B, Kovaleva, L, Salama, A, Jenkins, JM, Roychowdhury, D, Mayer, B, Stone, N, Arning, M
Less
LANCET[0140-6736],
Published 2009,
Volume 373,
Issue 9664,
Pages 641-648
收錄情况:
WOS
SCOPUS
WOS核心合集引用: 411
2023影響因子:
98.4
发表年影響因子:
30.758